Literature DB >> 23333597

Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.

Likun Li1, Guang Yang, Chengzhen Ren, Ryuta Tanimoto, Takahiro Hirayama, Jianxiang Wang, David Hawke, Soo Mi Kim, Ju-Seog Lee, Alexei A Goltsov, Sanghee Park, Michael M Ittmann, Patricia Troncoso, Timothy C Thompson.   

Abstract

In this study we report that expression of glioma pathogenesis-related protein 1 (GLIPR1) regulated numerous apoptotic, cell cycle, and spindle/centrosome assembly-related genes, including AURKA and TPX2, and induced apoptosis and/or mitotic catastrophe (MC) in prostate cancer (PCa) cells, including p53-mutated/deleted, androgen-insensitive metastatic PCa cells. Mechanistically, GLIPR1 interacts with heat shock cognate protein 70 (Hsc70); this interaction is associated with SP1 and c-Myb destabilization and suppression of SP1- and c-Myb-mediated AURKA and TPX2 transcription. Inhibition of AURKA and TPX2 using siRNA mimicked enforced GLIPR1 expression in the induction of apoptosis and MC. Recombinant GLIPR1-ΔTM protein inhibited AURKA and TPX2 expression, induced apoptosis and MC, and suppressed orthotopic xenograft tumor growth. Our results define a novel GLIPR1-regulated signaling pathway that controls apoptosis and/or mitotic catastrophe in PCa cells and establishes the potential of this pathway for targeted therapies.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23333597      PMCID: PMC3907183          DOI: 10.1016/j.molonc.2012.12.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  48 in total

1.  A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Authors:  M Gunther; M Laithier; O Brison
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

2.  Structural basis of Aurora-A activation by TPX2 at the mitotic spindle.

Authors:  Richard Bayliss; Teresa Sardon; Isabelle Vernos; Elena Conti
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

3.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  Aurora kinases: shining lights on the therapeutic horizon?

Authors:  Paul D Andrews
Journal:  Oncogene       Date:  2005-07-28       Impact factor: 9.867

Review 5.  Molecular chaperones and protein quality control.

Authors:  Bernd Bukau; Jonathan Weissman; Arthur Horwich
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

Review 6.  Mechanisms of drug-induced mitotic catastrophe in cancer cells.

Authors:  José Portugal; Sylvia Mansilla; Marc Bataller
Journal:  Curr Pharm Des       Date:  2010-01       Impact factor: 3.116

Review 7.  The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme?

Authors:  Italia Anna Asteriti; Wilhelmina Maria Rensen; Catherine Lindon; Patrizia Lavia; Giulia Guarguaglini
Journal:  Biochim Biophys Acta       Date:  2010-08-12

8.  Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene cluster.

Authors:  Chengzhen Ren; Cheng-Hui Ren; Likun Li; Alexei A Goltsov; Timothy C Thompson
Journal:  Genomics       Date:  2006-05-22       Impact factor: 5.736

Review 9.  Targeting aurora kinases in cancer treatment.

Authors:  Kevin R Kelly; Jeffrey Ecsedy; Devalingam Mahalingam; Steffan T Nawrocki; Swaminathan Padmanabhan; Francis J Giles; Jennifer S Carew
Journal:  Curr Drug Targets       Date:  2011-12       Impact factor: 3.465

Review 10.  The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions.

Authors:  Mads Daugaard; Mikkel Rohde; Marja Jäättelä
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

View more
  18 in total

1.  Targeting acute myeloid leukemia by drug-induced c-MYB degradation.

Authors:  V Walf-Vorderwülbecke; K Pearce; T Brooks; M Hubank; M M van den Heuvel-Eibrink; C M Zwaan; S Adams; D Edwards; J Bartram; S Samarasinghe; P Ancliff; A Khwaja; N Goulden; G Williams; J de Boer; O Williams
Journal:  Leukemia       Date:  2017-11-01       Impact factor: 11.528

2.  Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.

Authors:  Likun Li; Wenjun Chang; Guang Yang; Chengzhen Ren; Sanghee Park; Theodoros Karantanos; Styliani Karanika; Jianxiang Wang; Jianhua Yin; Parantu K Shah; Hirayama Takahiro; Masato Dobashi; Wenling Zhang; Eleni Efstathiou; Sankar N Maity; Ana M Aparicio; Elsa M Li Ning Tapia; Patricia Troncoso; Bradley Broom; Lianchun Xiao; Hyun-Sung Lee; Ju-Seog Lee; Paul G Corn; Nora Navone; Timothy C Thompson
Journal:  Sci Signal       Date:  2014-05-20       Impact factor: 8.192

3.  Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity.

Authors:  Lisa J Zhang; Yin Xiong; Naris Nilubol; Mei He; Swaroop Bommareddi; Xuguang Zhu; Li Jia; Zhen Xiao; Jeong-Won Park; Xia Xu; Dhaval Patel; Mark C Willingham; Sheue-Yann Cheng; Electron Kebebew
Journal:  Carcinogenesis       Date:  2015-01-09       Impact factor: 4.944

Review 4.  TPX2: of spindle assembly, DNA damage response, and cancer.

Authors:  Gernot Neumayer; Camille Belzil; Oliver J Gruss; Minh Dang Nguyen
Journal:  Cell Mol Life Sci       Date:  2014-02-21       Impact factor: 9.261

5.  Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.

Authors:  Likun Li; Guang Yang; Chengzhen Ren; Ryuta Tanimoto; Takahiro Hirayama; Jianxiang Wang; David Hawke; Soo Mi Kim; Ju-Seog Lee; Alexei A Goltsov; Sanghee Park; Michael M Ittmann; Patricia Troncoso; Timothy C Thompson
Journal:  Mol Oncol       Date:  2012-12-31       Impact factor: 6.603

6.  Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer.

Authors:  Theodoros Karantanos; Ryuta Tanimoto; Kohei Edamura; Takahiro Hirayama; Guang Yang; Alexei A Golstov; Jianxiang Wang; Shinji Kurosaka; Sanghee Park; Timothy C Thompson
Journal:  Int J Cancer       Date:  2013-11-01       Impact factor: 7.396

7.  AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment.

Authors:  Wei He; Min-Guang Zhang; Xiao-Jing Wang; Shan Zhong; Yuan Shao; Yu Zhu; Zhou-Jun Shen
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

Review 8.  Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.

Authors:  Junjie Wang; Zeyu Li; Fenfen Yin; Rui Zhang; Ying Zhang; Zhengxin Wang; Xiumei Sheng
Journal:  Cancer Gene Ther       Date:  2021-03-19       Impact factor: 5.987

9.  GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo.

Authors:  Urban J Scheuring; Steffi Ritter; Daniel Martin; Gabriele Schackert; Achim Temme; Stefanie Tietze
Journal:  J Neurooncol       Date:  2021-04-15       Impact factor: 4.130

10.  Key genes and drug delivery systems to improve the efficiency of chemotherapy.

Authors:  Zally Torres-Martinez; Yamixa Delgado; Yancy Ferrer-Acosta; Ivette J Suarez-Arroyo; Freisa M Joaquín-Ovalle; Louis J Delinois; Kai Griebenow
Journal:  Cancer Drug Resist       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.